The Efficacy and Safety of ZR2 Versus R-CHOP-like Regimen for Elderly Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma.
Clinical trial NCT05428670 · UNKNOWN
Trial details
- NCT number
- NCT05428670
- Sponsor
- First Affiliated Hospital of Wenzhou Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-15
- Primary completion
- 2025-05-30
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.